Abstract:Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited renal disease characterized by many fluid‐filled cysts and interstitial fibrosis in the kidneys, leading to chronic renal failure. During cystogenesis the renal tubules undergo extensive structural alterations that are accompanied by altered cellular signalling, directly and/or indirectly regulated by the PKD1 and PKD2 proteins. Since transforming growth factor (TGF)‐β signalling modulates cell proliferation, differentiation, apoptosis, adhesion and migration of various cell types, we studied the activation of this signalling pathway in Pkd1‐mutant mouse models at different stages of the disease. Therefore, we analysed expression of the TGFβ–Smad signalling pathway and its target genes in different Pkd1 mutant mouse models in various stages of polycystic disease. Nuclear accumulation of P‐Smad2 in cyst lining epithelial cells was not observed in the initiation phase but was observed at mild and more advanced stages of PKD. This coincides with mild fibrosis and increased mRNA levels of TGFβ target genes, such as fibronectin, collagen type I, plasminogen activator inhibitor 1 and matrix metalloproteinase‐2. At this stage many interstitial fibroblasts were found around cysts, which also showed nuclear localization for P‐Smad2. However, bone morphogenetic protein (BMP) signalling, which can antagonize TGFβ signalling, is not affected, since nuclear expression of P‐Smad1/5/8 and expression of the BMP target gene, inhibitor of DNA binding/differential‐1 (ID‐1) is not altered compared to wild‐type controls. Also, human kidneys with progressive ADPKD showed increased nuclear localization of P‐Smad2, while in general expression of P‐Smad1/5/8 was weak. These results exclude TGFβ signalling at the initiation of cystogenesis, but indicate an important role during cyst progression and in fibrogenesis of progressive ADPKD. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Repulsive Guidance Molecule B Inhibits Renal Cyst Development Through the Bone Morphogenetic Protein Signaling Pathway.

Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation

Ginkgolide B Inhibits Renal Cyst Development in in Vitro and in Vivo Cyst Models

O19 Ganoderma Triterpenes Inhibit Kidney Cyst Development Via Down-Regulating the Ras/MAPK Signaling Pathway

Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease.

Elevated TGFβ–Smad Signalling in Experimental Pkd1 Models and Human Patients with Polycystic Kidney Disease

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

Repulsive Guidance Molecules, Novel Bone Morphogenetic Protein Co-Receptors, Are Key Regulators of the Growth and Aggressiveness of Prostate Cancer Cells

Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD

Inositol 1,4,5-Triphosphate Receptor 3 Promotes Renal Cyst Development in Autosomal Dominant Polycystic Kidney Disease

A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease

Ganoderic Acid A is the Effective Ingredient of Ganoderma Triterpenes in Retarding Renal Cyst Development in Polycystic Kidney Disease

RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism.

Combination of curcumin and ginkgolide B inhibits cystogenesis by regulating multiple signaling pathways

Repulsive Guidance Molecule B (rgmb) Plays Negative Roles in Breast Cancer by Coordinating Bmp Signaling

Deficiency of geranylgeranyl biphosphate synthase in kidney tubules causes cystic kidney disease

CD74 Promotes Cyst Growth and Renal Fibrosis in Autosomal Dominant Polycystic Kidney Disease

Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease

Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model

Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys.

Transcription factor FoxM1 promotes cyst growth in PKD1 mutant ADPKD